Loperamide hydrochloride vs. Imodium multi-symptom relief: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Loperamide hydrochloride and Imodium multi-symptom relief. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 98,635 people who take Loperamide hydrochloride and Imodium multi-symptom relief, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
98,635 people who take Loperamide hydrochloride and Imodium multi-symptom relief are studied.
What is Loperamide hydrochloride?
Loperamide hydrochloride has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 7,606 Loperamide hydrochloride users for its effectiveness, alternative drugs and more.
What is Imodium multi-symptom relief?
Imodium multi-symptom relief has active ingredients of loperamide hydrochloride; simethicone. It is often used in diarrhea. eHealthMe is studying from 4,825 Imodium multi-symptom relief users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Loperamide Hydrochloride (loperamide hydrochloride)
- Imodium Multi-Symptom Relief (loperamide hydrochloride; simethicone)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Loperamide Hydrochloride:
- not at all: 3.04 %
- somewhat: 20.53 %
- moderate: 31.37 %
- high: 32.51 %
- very high: 12.55 %
Imodium Multi-Symptom Relief:
- not at all: 14.81 %
- somewhat: 18.52 %
- moderate: 29.63 %
- high: 33.33 %
- very high: 3.7 %
Want to compare Loperamide hydrochloride with Imodium multi-symptom relief?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of:
- Loperamide hydrochloride (7,282 reports)
- Imodium multi-symptom relief (4,784 reports)
Common Loperamide hydrochloride side effects:
- Diarrhea: 1,030 reports
- Drug ineffective: 839 reports
- Fatigue (feeling of tiredness): 520 reports
- Fever: 426 reports
- Breathing difficulty: 322 reports
- Rashes (redness): 317 reports
- Pneumonia: 293 reports
Browse all side effects of Loperamide hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Imodium multi-symptom relief side effects:
- Drug ineffective: 1,182 reports
- Swallowing difficulty: 543 reports
- Acute upper airway obstruction (blockage occurs in the upper airway): 241 reports
- Diarrhea: 210 reports
- Constipation: 141 reports
Browse all side effects of Imodium multi-symptom relief:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on loperamide hydrochloride and loperamide hydrochloride; simethicone (the active ingredients of Loperamide hydrochloride and Imodium multi-symptom relief, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Azathioprine and Ovarian Atrophy - 17 seconds ago
- Acebutolol Hydrochloride vs. Vaseretic - 22 seconds ago
- Benazepril Hydrochloride and Nexavar drug interaction - 46 seconds ago
- Amlodipine and Adnexa Uteri Cyst - 46 seconds ago
- Augmentin '125' and Cataract - 46 seconds ago
- Mirtazapine and Elevated Mood - 49 seconds ago
- Lortab and Carac drug interaction - 53 seconds ago
- Keflex and Clotrimazole drug interaction - 54 seconds ago
- Valproate Sodium and Raynaud'S Phenomenon - 54 seconds ago
- Hypophagia and Mouth Ulcers - 59 seconds ago